📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. (2014)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nature13862

PubMed Identifier: 25337873

Publication URI: http://europepmc.org/abstract/MED/25337873

Type: Journal Article/Review

Volume: 515

Parent Publication: Nature

Issue: 7525

ISSN: 0028-0836